This episode goes deep on the science of psychedelic-assisted therapy and research in light of some really astounding Phase III clinical trials that have recently come out about some of these substances. I am here with Amy Emerson, the CEO of the MAPS Public Benefit Corporation of the Multidisciplinary Association for Psychedelic Studies. Just as …